Primary tabs

3DDS: Alzheimer's Disease Drug Discovery in 3-D

Researchers: 
Funding year(s): 
2015 to 2016
Funding to date: 
$300,000

We propose to examine biological fluids from cells treated with individual drugs that have been approved previously by the U.S. Food and Drug Administration for the treatment of numerous diseases and disorders. We will determine whether these drugs reduce the levels of the toxic proteins known to cause Alzheimer’s disease. Newly identified drugs or similar modified compounds will be developed as Alzheimer’s therapeutics.